Influence of long inhaled corticosteroids use on community-acquired pneumonia course in patients with chronic respiratory diseases
With purpose of finding clinical features, estimation of accordance and effectiveness of antibacterial therapy, early and late outcome of community-acquired pneumonia (CAP) in patients with chronic respiratory diseases used inhaled corticosteroids (ICS), a prospective comparative study of 143 patients (male - 78 (54,5%), average age - 64,0±14,5) was conducted. ICS were taken by 44 patients, 99 patients did not use ICS. Clinical presentation, severity and dynamics of CAP were not statistically differed in both groups. Almost all patients received antimicrobial medicines recommended for CAP therapy in hospital. Initially prescribed antibiotics were effective half of the patients in both groups. Basic treatment with ICS for chronic respiratory diseases did not influence on the early and late outcome of CAP.